CRO · Private company · Hinckley, OH, US
Icon Government And Public Health Solutions, Inc.
Track this companyFree. Adds Icon Government And Public Health Solutions, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards8
- TASK D10: A PHASE 1 TRIAL TO EVALUATE A TREATMENT FOR CLOSTRIDIOIDES DIFFICILEFiscal year 2026 · $2.1MNIH RePORTER 75N93022D00018-P00001-759302500001-1 · fetched Nov 12, 2026
- Early Phase Clinical Trial Units (EPCTU)Fiscal year 2026 · $161.3KNIH RePORTER 75N93022D00018-P00004-759302200001-1 · fetched Nov 12, 2026
- TASK D10: A PHASE 1 TRIAL TO EVALUATE A TREATMENT FOR CLOSTRIDIOIDES DIFFICILEFiscal year 2025 · $370.1KNIH RePORTER 75N93022D00018-0-759302500001-1 · fetched Nov 12, 2026
- Early Phase Clinical Trial Units (EPCTU)Fiscal year 2025 · $160.1KNIH RePORTER 75N93022D00018-P00003-759302200001-1 · fetched Nov 12, 2026
- Vendor Audit Support Through the Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) ContractFiscal year 2024 · $3.9MNIH RePORTER 75N93021D00027-0-759302400001-1 · fetched Nov 12, 2026
- Vendor Audit Support Through the Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) ContractFiscal year 2024 · $5.3MNIH RePORTER 75N93021D00027-0-759302400001-2 · fetched Nov 12, 2026
- Task A: Early Phase Clinical Trial Units (EPCTU)Fiscal year 2024 · $164.1KNIH RePORTER 75N93022D00018-P00002-759302200001-1 · fetched Nov 12, 2026
- Task C1D1: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Antibiotic-Resistant TuberculosisFiscal year 2024 · $59KNIH RePORTER 75N93022D00018-P00002-759302300001-1 · fetched Nov 12, 2026